PRCTPROCEPT BioRobotics Corporation
$18.40-51% 1Y
$18.40
$16.6952 weeks$39.15
The financials
PROCEPT BioRobotics Corporation by the numbers
PROCEPT BioRobotics Corporation (PRCT) reported revenue of $94M in Q2 2026 (quarter ended Jun 30, 2026), up 19% from the same quarter a year earlier. That came with a gross margin of 66% and net loss of $27M. For the full year FY2025, revenue was $308M (+37% year on year) and net income −$96M. Its largest product in Q2 2026 was Hand Pieces And Other Consumables at $48M, 58% of the disclosed total, well ahead of System Sales And Leases at 35%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $94M | $79M | +19% |
| Gross profit | $62M | $52M | +21% |
| Operating income | −$27M | −$22M | n/a |
| Net income | −$27M | −$20M | n/a |
| Diluted EPS | −$0.47 | −$0.35 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Hand Pieces And Other Consumables | $48M | 58% |
| System Sales And Leases | $29M | 35% |
| Service | $6.0M | 7.2% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $83.4M (+16%)
Service grew +37% year on yearHand Pieces And Other Consumables +12% year on year
Segment Latestquarter on quarteryear on year
- Hand Pieces And Other Consumables$48.4M$48.4Mquarter on quarter +12%year on year +12%+12%+12%
- System Sales And Leases$29.1M$29.1Mquarter on quarter n/ayear on year +32%n/a+32%
- Service$6.0M$6.0Mquarter on quarter +6.6%year on year +37%+6.6%+37%
On our screens:Most shorted stocks